Metter Ge
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Viral-associated cancers and disorders
Papers in
-
- Cutaneous lymphoproliferative disorders research 3
-
- Hematopoietic Stem Cell Transplantation 2
- Journals
- Blood (5 papers)American Journal of Roentgenology (1 paper)PubMed (7 papers)
- Partner nations
- United StatesMalaysiaIndia
In The Last Decade
Metter Ge
13 papers receiving 490 citations
Peers
Comparison fields: 5 of 67
- Hematology 189
- Oncology 261
- Pathology and Forensic Medicine 127
- Genetics 59
- Dermatology 49
Countries citing papers authored by Metter Ge
This map shows the geographic impact of Metter Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Metter Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Metter Ge more than expected).
Fields of papers citing papers by Metter Ge
This network shows the impact of papers produced by Metter Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Metter Ge. The network helps show where Metter Ge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Metter Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. | 1987 | 64 |
| 2 | 1987 | 139 | |
| 3 | 1986 | 3 | |
| 4 | 1986 | 67 | |
| 5 | 1983 | 2 | |
| 6 | 1983 | 22 | |
| 7 | Phase I and preliminary phase II observations of high-dose intermittent 6-thioguanine. | 1981 | 7 |
| 8 | DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine. | 1980 | 19 |
| 9 | Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors. | 1978 | 5 |
| 10 | 1977 | 34 | |
| 11 | Phase II study of 5-azacytidine in solid tumors. | 1977 | 38 |
| 12 | DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). | 1976 | 28 |
| 13 | Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. | 1976 | 110 |
About Metter Ge
Metter Ge is a scholar working on Dermatology, Hematology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 13 papers that have together received 538 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Cutaneous lymphoproliferative disorders research (3 papers), Viral-associated cancers and disorders (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), HIV/AIDS drug development and treatment (2 papers), Cancer therapeutics and mechanisms (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Lymphadenopathy Diagnosis and Analysis (1 paper). The work is most often cited by research in Hematology (189 citations), Oncology (261 citations), Pathology and Forensic Medicine (127 citations), Genetics (59 citations) and Dermatology (49 citations). Metter Ge has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include Fletcher Ws, Grage Tb, Weiss Aj, KG Blume, MR O’Donnell, AP Nademanee, DS Snyder, GM Schmidt, JL Fahey and SJ Forman. Their work appears in journals such as Blood, American Journal of Roentgenology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.